End‐organ protective effect of serelaxin in patients hospitalized for heart failure: Results of the biomarker substudy of Relaxin in Acute Heart Failure‐2 (RELAX‐AHF‐2)
End-organ protective effect of serelaxin in patients with acute heart failure. CV, cardiovascular; HF, heart failure; NT-proBNP, N-terminal pro-B-type natriuretic peptide.